Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postural and ibopamine challenge comparison in progressive versus non-progressive glaucoma
2009-015916-16Phase 4Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Ibopamine in Glaucoma and open-angle glaucoma (OAG) (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Proportion of patients with intraocular pressure rise greater than 3 mmHg. Started Sep 2009; status: terminated.
02
Drugs
Ibopamine
03
Conditions
Glaucomaopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2009-015916-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015916-16.